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Editorial on the Research Topic
The Association of Other Autoimmune Diseases in Patients With Thyroid Autoimmunity
Autoimmune thyroid diseases (AITD) derive from a dysregulation of the immune system causing
an immune attack on the thyroid, and involve twomain clinical presentations: Graves’ disease (GD)
and Hashimoto’s thyroiditis (AT) (1).
Recently, a significant increase of the prevalence of other autoimmune disorders in AT patients
has been shown (by a large prospective, case-control, study) for the following diseases: vitiligo (Vit),
chronic autoimmune gastritis (CAG), sjogren disease (SS), rheumatoid arthritis (RA), multiple
sclerosis, polymyalgia rheumatica (Polym), celiac disease, diabetes, systemic lupus erythematosus
(SLE), sarcoidosis (S), alopecia, psoriathic arthritis (PsA), systemic sclerosis (SSc), and hepatitis
C virus (HCV)-related mixed cryoglobulinemia (MC); and a near significant prevalence has also
been shown for Addison’s disease and ulcerative colitis (2). Furthermore, the association of three
autoimmune disorders was observed in AT patients (the most frequent associations were AT +
CAG+ Vit and AT+ CAG+ Polym) (2).
Moreover, in a large number (n = 2,791) of UK patients with GD a significant association with
RA, pernicious anemia, SLE, Addison’s disease, celiac disease, and Vit has been shown. A relative
“clustering” of AITD in the index case with parental AITD was present. Furthermore relative risks
for most other coexisting autoimmune disorders were strongly increased among parents of index
cases (3).
Conversely, patients affected with the above mentioned autoimmune disorders are more
frequently affected by AITD (1).
In this Research Topic, constituted by eighteen papers, we review and discuss new evidence
about the association of other autoimmune diseases in patients with AITD, providing a stimulating
overview of the present knowledge.
The paper by Coppedè discusses the increasing evidence about the importance of epigenetic
modifications (such as changes in DNA methylation, non-coding RNA molecules-mediated gene
silencing, and covalent modifications of histone tails) in the pathogenesis of AITD, as a possible
result of environmental injuries that trigger these disorders.
The autoimmune/inflammatory syndrome induced by adjuvants (ASIA), presented by
Shoenfeld and Agmon-Levin (4), is constituted by different autoimmune conditions induced by
the exposure to various adjuvants, that are present in many vaccines, and induce immune reactions
(5). The review by Watad et al. summarizes the current knowledge on ASIA syndrome presented
as endocrinopathies, concentrating on adjuvants-associated AITD.
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Fallahi et al. provide evidence on the association of SSc and
thyroid disorders. The majority of the reviewed papers report an
association among SSc, hypothyroidism, and AT (and few cases
of GD). Moreover, a high prevalence of thyroid cancer, in SSc
patients with AT, has been observed.
Increased incidence of AT and hypothyroidism has been
shown in SLE patients, particularly in females. The review by
Ferrari et al. suggests female patients with SLE, showing a
high risk profile of AITD [a small and hypoechoic thyroid,
a thyroid-stimulating hormone (TSH) in the upper quartile
of the normal range, and antithyroid peroxidase antibodies
(AbTPO) positivity], should be periodically re-evaluated for
thyroid dysfunction, and when necessary due treatments.
Mixed cryoglobulinemia is the most important
systemic HCV-related extrahepatic disease (6). HCV is
a hepato- and lymphotropic virus responsible for many
autoimmune/lymphoproliferative and/or neoplastic disorders
and a high incidence of new cases of AT and thyroid dysfunctions
have been reported in MC patients (6). The paper by Ferri et al.
describes the prevalence and the clinical and serological
features associated with thyroid involvement, in particular AT
and papillary thyroid cancer, in patients affected by chronic
HCV infection in presence/absence of cryoglobulinemic
vasculitis.
Regarding RA, many studies have reported that the therapy
with biological antirheumatic agents (BAAs) are able to modify
the inflammatory response both in RA such as in AITD. The
paper by Bliddal et al. investigates how the use of such agents
affect the thyroid function and autoimmunity in RA patients.
Psoriasis (PsO) is a chronic autoimmune skin disease, and
PsA (a chronic inflammatory arthritis) is present in about 30%
of patients with PsO. An increased rate of new cases of patients
with positive AbTPO, hypothyroidism, thyroid dysfunctions and
appearance of a small thyroid with signs of hypoechogenicity,
overall in females, has been reported in PsA (7). PsO, PsA, and
their association with AITD have been evaluated by Ruffilli et al.
suggesting that a thyroid screening should be done routinely in
PsA female patients with an elevated risk pattern (a TSH level
in the upper quartile of the reference range, AbTPO positivity, a
small and hypoechogenic thyroid).
Also the association of S and thyroid autoimmunity has
been shown by different studies in a wide range of variability,
particularly in the female gender (8). Fazzi et al. provide
evidence about the possible association between S and thyroid
autoimmunity.
Sjögren’s syndrome and AITD frequently coexist in clinical
practice, leading to a complex overlapping disorder that
represents a particular example of the expression of heterogeneity
in patients with autoimmune disorders. Baldini et al. provide a
critical overview of the recent literature on the pathogenesis and
clinical features of SS-AITD overlapping disease.
Non-segmental Vit is an autoimmune disorder arising from
an autoimmune response against melanocytes in the skin, and it
is often associated with other autoimmune disorders (9). Baldini
et al. describe the clinical association between Vit and AITD and
evaluate the possible common molecular pathways involved in
their pathogenesis.
Lichen planus (LP) and lichen sclerosus (LS) are cutaneous-
mucous disorders, too. Their etiology is unknown, clinical and
histological data suggest an autoimmune pathogenesis; however
only few papers evaluated their association with AITD. Guarneri
et al. review the scientific literature about the correlation between
AITD and lichen, and the genetic risk factors in common between
these conditions.
Myasthenia gravis (MG) is a neuromuscular disease caused by
a deficient transmission of the nerve impulse to muscles, leading
to muscle weakness and exaggerated fatigue, that is mediated
by autoantibodies. AITD and MG are frequently associated;
their etiology is multifactorial and depends on genetic and
environmental factors. The review by Lopomo and Berrih-Aknin
focuses on AITD and MG, their common features and their
diversities.
The association between CAG and AITD has been first shown
at the beginning of 1960s, and recently has been included in
polyglandular autoimmune syndrome type IIIb (10). Cellini
et al. summarize the most recent achievements on this peculiar
association.
Santoro et al. evaluate the association between AT and
glomerulopathies. IgA nephropathy, membranous nephropathy,
membranoproliferative glomerulonephritis, focal segmental
glomerulosclerosis, amyloidosis, minimal change disease, and
antineutrophil cytoplasmic autoantibody (ANCA) vasculitis
are renal disorders frequently observed in AT. Different
hypotheses have been reported about the association between
AITD and glomerulopathies. A probable mechanism at the
basis of the association between ANCA vasculitis and AT is
the cross-reactivity between antigens in presence of a genetic
predisposition.
Moreover, this Research Topic evaluates also thyroid
autoimmunity during the complex period after childbirth,
that is critical for the de novo appearance or exacerbation
of autoimmune diseases, and AITD. Di Bari et al. describe
the postpartum thyroid diseases that consist of postpartum
thyroiditis (PPT), but also GD and non-autoimmune thyroiditis.
Postpartum mood disorders are a common form of maternal
psychiatric morbidity, owing to the rapid endocrine and
psychological alterations in the postpartum period (11).
Le Donne et al. discuss the interaction between thyroid
autoantibodies and mood disorders.
Antiphospholipid syndrome (APS) is an autoimmune
disorder manifesting as recurring venous or arterial thrombosis
that can induce complications during pregnancy and is
associated with the presence of persistent antiphospholipid
(aPL) autoantibodies. Versini conducts a literature review on the
present data on aPL/APS and AITD, and particularly on the role
of this association in obstetrical complications.
The exact pathogenetic mechanisms underlying the above
reported disorders are not completely known. The effect of
genetic on the association of different autoimmune disorders has
been shown, as: (a) there is significant clustering of AITD within
families (40–50% of AT patients have another family member
with AT) (12); (b) a clear evidence comes from twin studies
for GD (13) and AT (14) with concordance rates of 30–40% in
monozygotic twins and 0–7% in dizygotic twins.
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Moreover, new recent insights in genome-wide association
studies (GWAS) about autoimmune and immune-mediated
diseases have increased the knowledge of the pathogenesis
underlying these disorders (15), suggesting a common genetic
susceptibility (15).
Environmental factors [selenium, and vitamin D deficiency,
high iodine intake, exposure to radiation (owing to nuclear
fallout or medical irradiation)] are of particular importance
for the appearance of AITD in susceptible subjects (16).
Cigarette smoking is associated with GD and Graves’
ophthalmopathy (GO), although it reduces the risk of
hypothyroidism and thyroid autoimmunity. Also viral
infections can drive AITD, in particular human parvovirus
B19 (EVB19) and HCV. Regarding the various existing chemical
contaminants, pesticides and halogenated organochlorines
differently disrupt thyroid function. Polychlorinated
biphenyls and their metabolites and polybrominated
diethyl ethers bind to thyroid transport proteins (i.e.,
transthyretin), displace thyroxine, in this way disrupting
thyroid function. Considering drugs, interferon- and medicines
containing iodine have been associated with AITD. These
environmental issues have been presented in a recent paper by
Ferrari et al. (16).
A prevalent Th1 immune pattern has been shown in patients
with AT, GD, GO (17, 18), type 1 diabetes, SLE, SSc, RA, MC, and
others (19), in the initial phase of these disorders. Furthermore,
in GD, GO, SLE, MC (and others) a Th1 prevalence has been
shown in the active phase, that switches to a Th2 profile in the
inactive phase (20, 21) of the disease. So it has been hypothesized
that the influence of genetic and environmental factors could lead
to the onset of autoimmune phenomena in different organs in
the same subject (1), characterized by predominance of a Th1
immune pattern at the beginning, and in the active phase of these
disorders.
In conclusion, an association of other autoimmune diseases
in patients with thyroid autoimmunity has been shown, and this
Research Topic provides an extensive update of the literature, and
suggests interesting points for new investigations.
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